In the fission yeast Schizosaccharomyces pombe, the execution of Start requires the activity of the Cdc2 protein kinase and the CdclO/Sctl transcription complex. The loss of any of these genes leads to G1 arrest and activation of the mating pathway under appropriate conditions. We have undertaken a genetic and biochemical analysis of these genes and their protein products to elucidate the molecular mechanism that governs the regulation of Start. We demonstrate that serine-196 of CdclO is phosphorylated in vivo and provide evidence that suggests that phosphorylation of this residue is required for CdclO function. Substitution of serine-196 of CdclO with alanine (CdclO S196A) leads to inactivation of CdclO. We show that CdclO S196A is incapable of associating with Sctl to form a heteromeric complex, whereas substitution of this serine with aspartic acid (S196D) restores DNA-binding activity by allowing CdclO to associate with Sctl. Furthermore, we demonstrate that Cdc2 activity is required for the formation of the heteromeric Sctl/ CdclO transcription complex and that the CdclO S196D mutation alleviates this requirement. We thus provide biochemical evidence to demonstrate one mechanism by which the Cdc2 protein kinase may regulate Start in the fission yeast cell cycle.
INTRODUCTION
In eukaryotes, the passage of cells through the cell cycle is regulated in part by the association of multiple cyclin-dependent kinases (cdk) with different cyclin regulatory subunits. In yeast, a single 34-kDa cdk (Cdc2/CDC28) sequentially associates with G1, S-phase, or mitotic cyclins to form active holoenzyme complexes and thereby direct distinct cell cycle transitions. The developmental fate of the cell is determined by a series of regulatory events in the G1 termed Start. At this control point, a cell monitors both internal cues, such as cell size, and external cues, such as nutrient availability, and subsequently decides to proceed into a new round of mitotic cell division or to exit the cell cycle by activating functions leading to cellular differentiation. * In Saccharomyces cerevisiae, passage through Start requires the association of the CDC28 protein kinase with positive regulatory subunits known as G1 cyclins, CLNs. Three CLN type cyclins form a redundant multigene family that associates with the CDC28 protein kinase to control passage through G1 (Richardson et al., 1989) . Whereas the activity of any CLN gene product is sufficient to promote cell cycle progression, the loss of all three CLN genes results in cell cycle arrest at Start. In turn, overexpression of any CLN results in a shortened G1 and accelerates passage through Start. Thus, the decision to maintain mitotic cell cycle progression or to enter an alternative developmental fate is controlled in part by the association of CDC28 with CLN-type cyclins in G1.
Although the concept of cell cycle commitment at Start has been useful in describing yeast cell physiology, the underlying molecular basis of cell cycle commitment remains unclear. It is likely that one role of the Cdc2/CDC28 kinase in G1 is to directly activate transcription factors involved in regulating genes required for the activation of DNA replication. In budding yeast, the SWI4 and SWI6 proteins have been i 1997 by The American Society for Cell Biology identified as components of the SBF transcription complex that is required for the CDC28 (Start) dependent expression of the HO, CLN1, CLN2, HCS26, and PCL2 (ORFD) genes at the G1 /S-phase boundary (Breeden and Nasmyth, 1987a; Andrews and Herskowitz, 1989a; Nasmyth and Dirick, 1991; Ogas et al., 1991; Measday et al., 1994) . The SWI4 and SWI6 proteins have been implicated in the transcriptional control of the CLN1 and CLN2 genes through a positive feedback loop (Cross and Tinkelenberg, 1991; Dirick and Nasmyth, 1991; Ogas et al., 1991; ) . The CLN3/ CDC28 kinase complex is present throughout the cell cycle, and consequently, it has been proposed that this complex induces CLN1 and CLN2, which in turn leads to an abrupt rise in CDC28 kinase activity that is associated with the commitment of cells to enter the S-phase (Cross and Tinkelenberg, 1991) . Recent experiments, however, have shown that CLN3 is normally responsible for SBF-dependent transcription when cells reach a critical size at Start (Dirick et al., 1995; Stuart and Wittenberg, 1995) . Activation of the SW14/ SW16 complex at Start is thus thought to require phosphorylation by one or more members of the CLN/ CDC28 family of kinases (Cross and Tinkelenberg, 1991; Tyers et al., 1993; Koch et al., 1996) .
In the fission yeast S. pombe, three genes are known to be required for the execution of Start. These encode the Cdcl0 and Sctl /Resl transcription factors and the Cdc2 protein kinase, which is also required in G2 (Nurse and Bisset, 1981 , Tanaka et al., 1992 , Caligiuri and Beach, 1993 . Haploid strains carrying inactivating mutations in any of these genes arrest in G, and mate to form diploid cells under appropriate nutritional conditions. CdclO and Sctl share amino acid sequence similarity with the SWI4, SWI6, and MBP1 transcription factors from budding yeast (Aves et al., 1985; Breeden and Nasmyth, 1987b; Andrews and Herskowitz, 1989b; Tanaka et al., 1992; Caligiuri and Beach, 1993; Koch et al., 1993) . CdclO and Sctl function together as a heteromeric transcription complex to activate the expression of the cdc22, cdtl, and cdc18 genes at the G1-S-phase transition (Lowndes et al., 1992a; Caligiuri and Beach, 1993; Hofmann and Beach, 1994; Kelley et al., 1993) . Sctl and CdclO are thought to be directed to the promoters of these periodically expressed genes by the presence of Mlu 1-like elements (MCB) in their upstream regions, which have been shown to be sufficient to confer cell cycle periodicity on heterologous promoters (Lowndes et al., 1992a,b) . Sctl and CdclO are both expressed constitutively throughout the cell cycle; however, the DNA-binding activity of the transcription complex has been shown to oscillate (M.C., unpublished observation; Aves et al., 1985; Reymond et al., 1993) . This activity is dependent on Cdc2 function, thus phosphorylation of Sctl or CdclO may contribute to the regulation of the complex (Reymond et al., 1993) . We have undertaken a biochemical and genetic analysis of the Sctl /Cdcl0 transcription complex in S. pombe. We demonstrate that Cdc2 kinase activity is necessary for the formation of the CdclO/Sctl transcription complex. An analysis of the primary structure of CdclO revealed a single canonical Cdc2 phosphorylation site. We show that this site, which includes , is phosphorylated in vivo. Substitution of the serine residue within this site with an alanine (S196A), thus preventing phosphorylation, led to the dissociation of the Cdc10/Sctl complex. As a consequence, the CdclO S196A gene is incapable of functioning in vivo. Substitution of this serine with the negatively charged aspartic acid, thus potentially mimicking phosphorylation, restored the ability of CdclO to associate with Sctl and consequently to function in vivo. Furthermore, we demonstrate that Cdc2 kinase activity is essential for CdclO/Sctl complex formation, and that the CdclO S196D mutant bypasses this requirement. Thus, we provide biochemical and genetic evidence to suggest one mechanism by which the Cdc2 protein kinase may serve to regulate Start in the fission yeast cell cycle.
MATERIALS AND METHODS Strains and Media
All S. pombe strains were derived from a wild-type strain originally described by Leupold (1970 ,ig/ml (Beach et al., 1985) . The standard genetic procedures previously described for S. pombe were followed (Gutz et al., 1974) .
Immunoprecipitation and Western Blotting S. pombe cell-free lysates were prepared essentially as described (Booher et al., 1989 (Bradford, 1976) .
Molecular Biology of the Cell
Immunoprecipitations were performed with 10-50 mg of soluble protein extract and 1.0 ,ul of antibody as specified and were rotated at 4°C. After 2 h, 20 ,ul of a 1:1 slurry of protein-A Sepharose (Pharmacia Biotech, Piscataway, NJ) was added, and the incubation was continued for an additional 30 min at 4°C. The immune complexes were recovered by centrifugation and washed three times in 1.0 ml of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM DTT, and 1 mM PMSF. The samples were resuspended in Laemmli buffer, and the proteins were resolved by conventional SDS-PAGE. For immunoblotting, the proteins were transferred to nitrocellulose for 30 to 60 min at 400 mA with a semidry transfer apparatus (Millipore, Bedford, MA) . After the transfer, the immunoblots were blocked in TBST (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween 20) containing 5% nonfat dry milk for 30 min at 37°C. Blots were incubated with a 1:1,000 dilution of antibody in TBST 5% milk for 2 h at room temperature. The blots were washed three times (20 min each) in TBST and then incubated with a 1:50,000 dilution of an anti-mouse or anti-rabbit Fc antibody as appropriate (Jackson ImmunoResearch Laboratories, West Grove, PA) in TBST 5% milk for 1 h at room temperature. The proteins were visualized using an enhanced chemiluminescence kit (Amersham Life Science, Arlington Heights, IL) and conventional autoradiography.
Cdc25 Block Release
A strain (SP 530) carrying cdc25-22 was grown to mid-exponential phase in rich medium (YEA) at 25'C, and the cells were collected by centrifugation and inoculated into fresh media at 36°C for 3 h. The culture was then shifted back to 25'C, and 50-ml aliquots of cells were harvested at 30-min intervals. Cell extracts were prepared as described above.
Metabolic Labeling and Two-Dimensional Tryptic Peptide Mapping S. pombe cells were grown for approximately 16 h in phosphate-free minimal media in which the NaH2PO4 was reduced to 1 mM and the potassium phthalate was replaced with sodium acetate (Moreno et al., 1991) . The cells were harvested, 5-10 ml at 1 X 107 cells per ml, washed with H20, and resuspended in phosphate-free minimal media supplemented with 50 ,tM NaH2PO4. The cultures were incubated for 2 h before the addition of [P2P]orthophosphate (1 mCi/5 ml culture) and labeled for 3 to 4 h. Extracts were prepared for immunoprecipitation as described above.
The proteins subjected to tryptic mapping were eluted from gel slices in 50 mM ammonium bicarbonate ovemight in the presence of 20 ,ug of RNase. The proteins were precipitated with trichloroacetic acid and digested with 10 ,ug of L-1-tosylamide-2-phenylethylchloromethyl-trypsin as described (van der Geer et al., 1993) . Peptide maps were produced by two-dimensional separation of the phosphopeptides on TLC plates. The first dimension was electrophoresis in pH 1.9 buffer, and the second dimension was chromatography in isobutyric acid buffer (van der Geer et al., 1993) .
Gel Retardation Assays
Cells were grown into a density of 5 x 106 to 1 X 107 cells/ml in minimal selective media, harvested by centrifugation, and washed once in lysis buffer (50 mM Tris, pH 7.5, 0.3 M KCl, 10% glycerol, 10 mM MgCl2, 20 mM 13-glycero-phosphate, 5 mM EDTA, 0.1 mM sodium vanadate, 1 mM DTT, 0.2% NP40, 1 mM PMSF, 2 Ag/ml leupeptin, aprotinin, and pepstatin). The cells were disrupted by vortexing with glass beads. Cellular debris was cleared from the lysate by centrifugation for 20 min in a microcentrifuge. The supernatant was collected, and the protein concentration was determined by a colorimetric assay using Bradford reagent (Bradford, 1976) .
The restriction fragments to be used for probes were recovered from low-melting-temperature agarose in Tris-acetate buffer and end labeled with Klenow polymerase in the presence of [a-32P]dATP (Sambrook et al., 1989) . The binding reactions were performed in a volume of 20 ,ul and contained 20 jig of lysate in 20 mM Tris (pH 7.5), 50 mM KCl, 10 mM MgCl2, 5% glycerol, 2 mM DTT, 1 mM ATP, 0.1 mg/ml poly(dIdC)-poly(dIdC) (Pharmacia, Piscataway, NJ). After the addition of the protein extracts, the reaction mixtures were incubated at room temperature for 10 min. Approximately 1 ng of probe at 107 cpm/,ug was added to the binding reaction, and the incubation was continued for an additional 10 min. When noted, unlabeled promoter fragment, at an approximately 50-fold M excess to the probe, was added at the same time as the probe. The anti-CdclO antibody and preimmune sera were diluted 10-fold in binding buffer, and 1 ,ul was added after the binding reaction. The HAl monoclonal antibody 12CA1 (Boehringer Mannheim, Indianapolis, IN) was purified on protein ASepharose as described by the manufacturer. The antibody was diluted 1:10 in binding buffer, and 1 ml was added to the reaction as above. The binding reaction was incubated for an additional 10 min after the addition of antibodies. The DNA protein complexes were resolved on a 4% polyacrylamide gel (30:0.8 cross-linking) in 0.5x Tris-borate EDTA. The gels were dried on Whatman 3MM paper and subjected to autoradiography.
RESULTS

CdclOISctl Function Requires the Cdc2 Consensus Site Within CdclO
The CdclO transcription factor is a phosphoprotein in vivo (Simanis and Nurse, 1989) , and analysis of its primary structure revealed a single Cdc2 consensus site (SPLR) at . We therefore explored the consequences of amino acid substitutions at by mutating this residue to the nonphosphorylatable alanine (S196A) and to the negatively charged aspartic acid (S196D) to potentially mimic phosphorylation. These mutant cdclO genes were then analyzed for their ability to complement the cdclO-129 temperature-sensitive mutation. The cdclO+, cdclO S196A, and cdclOS196D genes expressed on plasmids under the control of the cdclO promoter were transformed into a cdclO-129 strain (SP 965) under permissive conditions for this mutation (25°C). Individual transformants were then assayed for growth under permissive or restrictive (36°C) conditions. Transformants harboring an empty vector or the S196A mutant failed to grow at elevated temperature, indicating that Ser-196 is essential for CdclO function in vivo ( Figure 1A ). The S196D mutant was, however, capable of fully complementing the temperature-sensitive cdclO-129 mutation, suggesting that phosphorylation of this residue is critical for CdclO function. The cdclO S196D mutant displays a mild cell elongation phenotype indicative of cell cycle delay, which is similar to that observed upon overexpression of cdclO+/sctl+ (Ayte et al., 1995) .
The lack of cdclO-129 complementing activity by cdclO S196A could be explained if this mutant gene was not expressed or if its protein product was unstable. We therefore investigated the expression of The cdclO-129 mutant strain was transformed with either cdclO+, cdclO S196A, or cdclO S196D on a multicopy plasmid and grown on selective media at either 25'C (permissive) or 36'C (restrictive) as indicated. (B) Anti-CdclO immunoblot of immunoprecipitates using either preimmune serum (lane 1) or the anti-CdclO antibody (lanes 2-7) from extracts prepared from cells producing CdclO+ (lanes 2 and 3), CdclO S196A (lanes 4 and 5), or CdclO S196D (lanes 6 and 7) grown at either 25°C or 36'C as indicated.
cdcl0+, cdcl0 S196A, and cdcl0 S196D in the cdcl0-129 transformants at both the permissive and nonpermissive temperatures for this mutation ( Figure 1B , 1995) . We investigated whether the cell cycle periodicity of the DNA binding activity of this complex was due to an oscillation in Cdc1O/ Sctl association across the cell cycle (Reymond et al., 1993) . S. pombe cells carrying a temperature-sensitive allele of cdc25 (cdc25-22) display a tight cell cycle arrest in G2 when shifted to the nonpermissive temperature of 36°C and undergo synchronous cell division upon reintroduction into media at the permissive temperature (25°C) (Russell and Nurse, 1986) . A culture of a strain (SP 530) carrying the cdc25-22 allele harboring a plasmid expressing the sctl gene tagged at the 3' end with a triple tandem copy of the hemagglutinin (HA) epitope (Sctl-HA) was synchronized by restricting growth at 36°C for 3 h (Caligiuri and Beach, 1993) . The cells were then released into fresh media at the permissive temperature of 25°C, and aliquots were removed at 30-min intervals over a period of 6 h, corresponding to two cell cycles. Cell-free extracts were prepared, and the cell cycle profiles were monitored by measuring septation index ( Figure 3A ). Anti-HA immunoprecipitates were resolved by SDS-PAGE, transferred to a nitrocellulose membrane, and probed with the anti-CdclO polyclonal antibody (Figure 3B ) (Caligiuri and Beach, 1993) . Cells that carry the cdc2-33 and cdc2-M72 alleles are temperature sensitive for growth. Both of these mutants arrest in G1 and G2, although the cdc2-M72 mutant appears to have a more profound G1 defect that the cdc2-33 mutant. These extracts were immunoprecipitated with either a polyclonal antibody raised against CdclO or with a monoclonal antibody raised against the HA epitope (12CA5 Figure 4 . The association between CdclO and Sctl is dependent upon Cdc2 function in vivo. Cell-free extracts were prepared from wild-type, cdc2-33, and cdc2-M72 strains producing Sctl-HA grown at 27°C or 36°C as indicated. Immunoprecipitations were performed using either the CdclO preimmune sera or normal mouse serum (A and B, lane 1, respectively), the anti-CdclO antibody (A, lanes 2-7) or the anti-HA antibody (A, lanes 8-13; B, lanes 2-7). These immunoprecipitates were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and probed with antibodies raised against CdclO (A, lanes 1-13) or Sctl-HA (B, lanes 1-7) to visualize the CdclO and Sctl-HA proteins, respectively. conditions (36°C) and is thus not specific to a single allele of cdc2 ( Figure 4A, lanes 11 and 13) . Growth of the wild-type or cdc2 mutant strains at elevated temperature had no effect on the level of CdclO ( Figure  4A, lanes 3, 5, and 7) . Similarly, the level of Sctl was not affected in the wild-type or cdc2-33 strains grown at elevated temperature, but was, however, reduced in the cdc2-M72 strain ( Figure 4B, lanes 3, 5, and 7) . These results suggest, therefore, that Cdc2 function, which has been shown previously to be required for the DNA binding activity of the complex (Reymond et al., 1993) Sctl and CdclO S196A resolved by SDS-PAGE The CdclO+, CdclO+ Sctl, or CdclO S196A S were immunoprecipitated with the anti-Cdcl( by SDS-PAGE (lanes 5-7, respectively). (B) An immunoprecipitates using the CdclO preimmi extract (lane 1), the anti-CdclO antibody and C CdclO S196D extracts (lanes 2-4, respectively body and CdclO+, CdclO S196A, or CdclO SI respectively). (C) Anti-CdclO immunoblot of in cdc2-33 CdclO+, cdc2-33 CdclO S196A, and extracts prepared from strains growing at 27 using the CdclO preimmune serum or norma cdc2-33 CdclO+ (27°C) extract (lanes 1 and 8 CdclO antibody and cdc2-33 CdclO+, cdc, cdc2-33 CdclO S196D extracts (lanes 2 and respectively), and the anti-HA antibody cdc2-33 CdclO S196A, or cdc2-33 CdclO S19 and 13, 11 and 14, respectively).
( Figure 5A , lanes 1 and 2, respecti Sctl was cotranslated with CdclO1
( Figure 5A , lanes 3 and 4, respectix cipitation of these 35S-labeled proteins with the antiCdclO antibody revealed that Sctl was associated with CdclO+, but not, CdclO S196A ( Figure 5A , lanes 6 and 7, respectively). This suggests that the S196A mutation in CdclO does indeed prevent its association with Sctl, perhaps due to the nonphosphorylatable nature of this substitution. As described above Ser-196 is phosphorylated in vivo, we therefore infer that an activity capable of the phosphorylation of CdclO is present in these extracts. We went on to examine the consequence of mutations at in CdclO on complex formation with Sctl in vivo. For this purpose, cell-free extracts were prepared from wild-type strains (SP 812) producing either CdclO+, CdclO S196A, or CdclO S196D and Sctl-HA, grown at 27°C. Anti-CdclO ( Figure 5B , lanes 2-4) and anti-HA ( Figure 5B, lanes 5-7) immunoprecipitates were resolved by SDS-PAGE, blotted to nitrocellulose and probed with the anti-CdclO antibody. Cdc1O+ and CdclO S196D were both found to be associated with Sctl-HA ( Figure 5B , lanes 5 and 7, respectively), whereas CdclO S196A was not ( Figure  5B , lane 6). All three forms of CdclO were clearly detectable in these extracts ( Figure 5B , lanes 2-4), indicating that the loss of the association between CdclO S196A and Sctl-HA was not due to a loss of CdclO S196A protein. This result suggests that phosphorylation of CdclO at Ser-196 is required for its stable association with Sctl.
As described above phosphorylation of CdclO at 270
36°Ser-196 appears to be required for CdclO to associate with Sctl. Because Ser-196 lies within a Cdc2 consen--_ sus site and Cdc2 is required for CdclO/Sctl complex 9 10 11 12 13 14 formation, we examined the possibility that CdclO S196D might bypass this requirement because the negfor complex formation ative charge at residue 196 may mimic constitutive th 3S from rabbit reticu-phosphorylation. To test this hypothesis, cell-free ex-+, Sctl and CdclO+, or tracts were prepared from strains that carry the (la translaton pecrodelyc)t cdc2-33 mutation and that produce CdclO+, CdclO O antibody and resolved S196A, or CdclO S196D and Sctl-HA grown at 27°C ti-CdclO immunoblot of and then shifted to 36°C for 3 h. As expected, CdclO+ une serum and CdclO+ and CdclO S196D were found to be associated with 'dclO+, CdclO S196A, or Sctl-HA in extracts prepared from the cdc2-33 strain r) and the anti-H-A anti-196D extracts (lanes 5-7, grown under permissive conditions ( Figure 5C , lanes nmunoprecipitates from 9 and 11, respectively), whereas CdclO S196A was not cdc2-33 CdclO S196D
( Figure 5C , lane 10). As shown above, inactivation of 'C or 36'C as specified, Cdc2 by growth under restrictive conditions led to the I mouse serum and the loss of the association between CdclO+ and Sctl-HA 1,respectively), the anti-2-33 CdclO S196A, or ( Figure 5C , lane 12). As predicted, CdclO S196D did, in 1 5, 3 and 6, 4 and 7, fact, associate with Sctl-HA under these conditions and cdc2-33 CdclO+, ( Figure 5C , lane 14) thus bypassing the requirement of 6D (lanes 9 and 12, 10 Cdc2 for CdclO/Sctl complex formation. The inactivation of Cdc2 did not alter the level of CdclO+, CdclO S196A, or CdclO S196D protein ( Figure 5C , vely). In addition, lanes 2-7). The results of this experiment suggest that Caligiuri and Beach, 1993) . We therefore trans--z -z zformed this strain with plasmids expressing cdclO+, 1j W cdclO S196A, and cdclO S196D to assay the DNA-_ -,,,,_ binding activity of these phosphorylation site mutants. For this purpose, protein extracts were prepared from these transformants grown under permissive conditions for the cdclO-129 mutation and incubated at either 25°C or 32°C for 15 min in vitro. As shown in * S Figure 6 , a specific band was detected when the extract prepared from the strain producing CdclO+ was incubated with the cdc22 promoter fragment ( Figure CdclO S196A strain when assayed under permissive *IZgui Z s sconditions (Figure 6, lane 5) . The low activity in this extract indicates that CdclO S196A is incapable of complementing the endogenous activity and that the S196A mutation renders CdclO inactive. It does not t <1 1 l2 13 1:4 appear that CdclO S196A prevents the gel shift as the level of activity seen in this experiment is similar to CdclOSGelretalrdaconplessarys that observed with cdclO-129 extracts (Lowndes et al., noter fragment using extracts 1992a; Caligiuri et al., 1993) . CdclO S196D was found ducing either CdclO+ (lanes to restore the DNA-binding activity to the level obies 5 and 6 and 11 and 12), or tained with CdclO+ ( Figure 6, lane 7) . This complex is )ated at either 250C (lanes1-8) CdclO of this serine with alanine (S196A) results in a loss of complementing activity in vivo. We show that this is due to the inability of the CdclO S196A mutant to associate with Sctl in vivo. As a consequence, the Sctl /CdclO transcription complex is incapable of binding to its target promoters. It is formally possible that CdclO S196A does not localize properly to the nucleus, which could thus account for its lack of complementing activity (Reymond et al., 1993) . The finding, however, that CdclO+ associates with Sctl in vitro, whereas CdclO S196A does not, suggests that if this is the case complex formation precedes nuclear localization. Substitution of this serine with aspartic acid, potentially mimicking phosphorylation, restores the ability of CdclO to complex with Sctl and thus its function in vivo. Interestingly, the CdclO S196D mutation bypasses the requirement for Cdc2 activity in Sctl /CdclO complex formation. We therefore propose that the Cdc2 protein kinase functions to control the affinity of CdclO for its cognate partner, Sctl.
The demonstration that CdclO S196D alleviates the requirement of Cdc2 for its association with Sctl strongly implicates the involvement of Cdc2 in the phosphorylation of Ser-196. In the accompanying article (Caligiuri et al., 1997) , we demonstrate that the Ranl kinase is also involved in Ser-196 phosphorylation. Thus, we conclude that Ranl and Cdc2 function together to control the phosphorylation of CdclO at Ser-196. It is currently unclear which kinase acts directly to phosphorylate CdclO. Ran 1 has been implicated as a mediator of the cellular response to nutritional deprivation. In this respect, CdclO, whose phosphorylation state may influence the developmental program, leading to either cellular proliferation or differentiation, may be a substrate of both the Cdc2 and Ran 1 kinases under conditions of cellular stress.
It is clear that CdclO has at least two DNA binding partners, Sctl and Pctl, giving rise to two distinct heteromeric DNA-binding complexes (Caligiuri and Beach, 1993; Miyamoto et al., 1994; Zhu et al., 1994) . Genetic analyses of strains deleted for sctl or pctl demonstrate that their roles in the cell cycle are, in fact, different. The pctl gene is not essential for mitotic cell cycle progression, null mutants do not display adverse effects on cell viability or growth rate (Miyamoto et al., 1994; Zhu et al., 1994) . Deletion of sctl is, however, a lethal event resulting simultaneously in G, arrest and derepression of mating functions (Caligiuri and Beach, 1993) . Although sctl null mutants are derepressed for meiosis, it appears that the meiotic pathway can proceed normally (Caligiuri and Beach, 1993) .
In contrast, the pctl gene product appears to play a major role in meiosis, which is severely disrupted in the null mutant (Miyamoto et al., 1994; Zhu et al., 1994) . These results suggest that Sctl plays a more critical role in the mitotic cell cycle than Pctl, which appears to function predominantly in meiosis, although Pctl can contribute to the transcriptional regulation at Start under some circumstances (Miyamoto et al., 1994; Zhu et al., 1994) .
The sctl and pctl genes are both expressed during mitotic growth though pctl is greatly induced upon nitrogen starvation, thus their protein products are present simultaneously in the cell (Miyamoto et al., 1994; Zhu et al., 1994) . The ratio of the Sctl/CdclO complex to the Pctl/CdclO therefore may be regulated by the phosphorylation state of CdclO. In this case, CdclO phosphorylated on Ser-196 may display a higher affinity for Sctl, and conversely, unphosphorylated CdclO (at least with respect to this site) may display a higher affinity toward Pctl. It is conceivable that phosphorylation of CdclO at Ser-196 is not required for Pctl /CdclO function because unlike CdclO, Sctl, and Cdc2, loss of Pctl does not lead to G, arrest (Miyamoto et al., 1994; Zhu et al., 1994) . Upon loss of Cdc2, CdclO may become under-phosphorylated at specific residues and the Pctl/CdclO complex would dominate. Cells that arrest in G1 then would be competent to exit the cell cycle and activate mating functions under appropriate nutritional conditions if challenged by a cell of the opposite mating type. It follows that the sctl null mutant is derepressed for meiotic activation simply because Sctl is not present to compete with Pctl for its cognate partner, CdclO. Alternatively, another kinase could phosphorylate CdclO upon meiotic activation. When cells are starved for nitrogen, no significant change in the level of CdclO is detected and CdclO remains phosphorylated (Simanis and Nurse, 1989) . Subtle changes in phosphorylation sites may occur, however, and thereby account for potential differences in the affinity of CdclO for either Sctl or Pctl. It will be interesting to determine whether the presence of the canonical Cdc2 phosphorylation site in CdclO is necessary for its association with Pctl.
A number of transcription factors contain ankyrin repeat motifs and achieve specificity in transcriptional regulation through formation of specific heteromeric complexes (Thompson et al., 1991; Sawanda et al., 1994) . It has been suggested that ankyrin repeats play an important role by providing an interface for protein-protein interactions (Thompson et al., 1991) . The CdclO/Sctl proteins, which both contain a pair of ankyrin repeats, thus possess hallmarks of an evolutionarily conserved mechanism to regulate gene expression. The results presented here indicate that a specific phosphorylation in a non-ankyrin-like domain dramatically influences the ability of one protein to stably associate with its heteromeric partner and form an active DNA-binding complex. It is thus possible that phosphorylation will play an important and conserved role in controlling the highly specific interactions among these proteins to regulate key developmental processes.
